• Treffer 7 von 13
Zurück zur Trefferliste

Extracellular Vesicles in Musculoskeletal Pathologies and Regeneration

Zitieren Sie bitte immer diese URN: urn:nbn:de:bvb:20-opus-222882
  • The incidence of musculoskeletal diseases is steadily increasing with aging of the population. In the past years, extracellular vesicles (EVs) have gained attention in musculoskeletal research. EVs have been associated with various musculoskeletal pathologies as well as suggested as treatment option. EVs play a pivotal role in communication between cells and their environment. Thereby, the EV cargo is highly dependent on their cellular origin. In this review, we summarize putative mechanisms by which EVs can contribute to musculoskeletal tissueThe incidence of musculoskeletal diseases is steadily increasing with aging of the population. In the past years, extracellular vesicles (EVs) have gained attention in musculoskeletal research. EVs have been associated with various musculoskeletal pathologies as well as suggested as treatment option. EVs play a pivotal role in communication between cells and their environment. Thereby, the EV cargo is highly dependent on their cellular origin. In this review, we summarize putative mechanisms by which EVs can contribute to musculoskeletal tissue homeostasis, regeneration and disease, in particular matrix remodeling and mineralization, pro-angiogenic effects and immunomodulatory activities. Mesenchymal stromal cells (MSCs) present the most frequently used cell source for EV generation for musculoskeletal applications, and herein we discuss how the MSC phenotype can influence the cargo and thus the regenerative potential of EVs. Induced pluripotent stem cell-derived mesenchymal progenitor cells (iMPs) may overcome current limitations of MSCs, and iMP-derived EVs are discussed as an alternative strategy. In the last part of the article, we focus on therapeutic applications of EVs and discuss both practical considerations for EV production and the current state of EV-based therapies.zeige mehrzeige weniger

Volltext Dateien herunterladen

Metadaten exportieren

Weitere Dienste

Teilen auf Twitter Suche bei Google Scholar Statistik - Anzahl der Zugriffe auf das Dokument
Metadaten
Autor(en): Marietta Herrmann, Solvig Diederichs, Svitlana Melnik, Jana Riegger, Drenka Trivanović, Shushan Li, Zsuzsa Jenei-Lanzl, Rolf E. Brenner, Markus Huber-Lang, Frank Zaucke, Frank A. Schildberg, Susanne Grässel
URN:urn:nbn:de:bvb:20-opus-222882
Dokumentart:Artikel / Aufsatz in einer Zeitschrift
Institute der Universität:Medizinische Fakultät / Lehrstuhl für Orthopädie
Sprache der Veröffentlichung:Englisch
Titel des übergeordneten Werkes / der Zeitschrift (Englisch):Frontiers in Bioengineering and Biotechnology
ISSN:2296-4185
Erscheinungsjahr:2021
Band / Jahrgang:8
Aufsatznummer:624096
Originalveröffentlichung / Quelle:Frontiers in Bioengineering and Biotechnology 2021, 8:624096. doi: 10.3389/fbioe.2020.624096
DOI:https://doi.org/10.3389/fbioe.2020.624096
Allgemeine fachliche Zuordnung (DDC-Klassifikation):6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Freie Schlagwort(e):MSC; cell-free therapeutics; exosomes; extracellular vesicles; iMP; musculoskeletal diseases
Datum der Freischaltung:15.03.2021
Datum der Erstveröffentlichung:20.01.2021
Open-Access-Publikationsfonds / Förderzeitraum 2020
Lizenz (Deutsch):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International